Home Resources Biotech and Pharmaceutical 2020 Report - Research Report by BlueVoyant Biotech and Pharmaceutical 2020 Report – Research Report by BlueVoyant December 11, 2020 BlueVoyant Report Reveals Biotech and Pharmaceutical Industry under Aggressive and Targeted Attack. As the industry ramps up global vaccine production and distribution, the report highlights the attack types and emerging threats that are likely to intensify. Key findings include: The number one emerging threat in 2020 is nation-state espionage aimed at stealing COVID-19 vaccine research data. That said, the top threat overall is still ransomware. COVID-19 vaccines are the crown jewels in 2020 with eight of the most prominent companies in the race for a vaccine facing high volumes of targeted malicious attacks. Analysis of threat intelligence data shows that biotech and pharmaceutical companies are under massive and daily attack Of the 25 attacks reported to the media since 2017, 10 (40%) took place in 2020. Read more around the key implications that the biotech and pharmaceutical industries are facing and how to monitor and mitigate these new attack vectors during the most critical time in their existence. “2020 Biotech and Pharmaceutical Report” Share: Facebook Twitter LinkedIn Related reading Resources Sign up for our Cyber Security Model Certification (CMMC) Newsletter Sign up for our Cyber Security Model Certification (CMMC) Newsletter The Cybersecurity Maturity Model Certification (CMMC) is a new cybersecurity… Read more News Cybersecurity Veteran James M. Aquilina Joins BlueVoyant as Member of Advisory Board and Advisor to the CEO Visionary leader Aquilina brings deep expertise in building world class growth stage incident response, digital forensics, threat intelligence, and… Read more Video Migrating to a Cloud-Based SIEM An in-depth discussion and deep dive into Microsoft Azure Sentinel with BlueVoyant’s Robert Hannigan, Micah Heaton, and also featuring Managed… Read more Recommended reading Resources Sign up for our Cyber Security Model Certification (CMMC) Newsletter Sign up for our Cyber Security Model Certification (CMMC) Newsletter The Cybersecurity Maturity Model Certification (CMMC) is a new cybersecurity…
December 11, 2020 BlueVoyant Report Reveals Biotech and Pharmaceutical Industry under Aggressive and Targeted Attack. As the industry ramps up global vaccine production and distribution, the report highlights the attack types and emerging threats that are likely to intensify. Key findings include: The number one emerging threat in 2020 is nation-state espionage aimed at stealing COVID-19 vaccine research data. That said, the top threat overall is still ransomware. COVID-19 vaccines are the crown jewels in 2020 with eight of the most prominent companies in the race for a vaccine facing high volumes of targeted malicious attacks. Analysis of threat intelligence data shows that biotech and pharmaceutical companies are under massive and daily attack Of the 25 attacks reported to the media since 2017, 10 (40%) took place in 2020. Read more around the key implications that the biotech and pharmaceutical industries are facing and how to monitor and mitigate these new attack vectors during the most critical time in their existence. “2020 Biotech and Pharmaceutical Report” Share: Facebook Twitter LinkedIn Related reading Resources Sign up for our Cyber Security Model Certification (CMMC) Newsletter Sign up for our Cyber Security Model Certification (CMMC) Newsletter The Cybersecurity Maturity Model Certification (CMMC) is a new cybersecurity… Read more News Cybersecurity Veteran James M. Aquilina Joins BlueVoyant as Member of Advisory Board and Advisor to the CEO Visionary leader Aquilina brings deep expertise in building world class growth stage incident response, digital forensics, threat intelligence, and… Read more Video Migrating to a Cloud-Based SIEM An in-depth discussion and deep dive into Microsoft Azure Sentinel with BlueVoyant’s Robert Hannigan, Micah Heaton, and also featuring Managed… Read more Recommended reading Resources Sign up for our Cyber Security Model Certification (CMMC) Newsletter Sign up for our Cyber Security Model Certification (CMMC) Newsletter The Cybersecurity Maturity Model Certification (CMMC) is a new cybersecurity…
Resources Sign up for our Cyber Security Model Certification (CMMC) Newsletter Sign up for our Cyber Security Model Certification (CMMC) Newsletter The Cybersecurity Maturity Model Certification (CMMC) is a new cybersecurity… Read more
News Cybersecurity Veteran James M. Aquilina Joins BlueVoyant as Member of Advisory Board and Advisor to the CEO Visionary leader Aquilina brings deep expertise in building world class growth stage incident response, digital forensics, threat intelligence, and… Read more
Video Migrating to a Cloud-Based SIEM An in-depth discussion and deep dive into Microsoft Azure Sentinel with BlueVoyant’s Robert Hannigan, Micah Heaton, and also featuring Managed… Read more
Resources Sign up for our Cyber Security Model Certification (CMMC) Newsletter Sign up for our Cyber Security Model Certification (CMMC) Newsletter The Cybersecurity Maturity Model Certification (CMMC) is a new cybersecurity…
